OHSU is Oregon’s most admired health care company, according to Portland Business Journal’s annual ranking; OHSU Doernbecher (#7) and OHSU Knight Cancer Institute (#11) are also recognized.
A feature story highlights the first OHSU Doernbecher patient to receive a new, at-home oral treatment for spinal muscular atrophy. Erika Finanger, M.D., says the promising treatment will become more effective if given to patients early in life, suggesting the importance of newborn screening for the condition.
OHSU is postponing its 2020 Doernbecher Freestyle program and event, where young patients design tennis shoes that are sold to benefit Doernbecher Children’s Hospital, due to the pandemic.